Table 2.
Clinical evidence for dietary calcium-sensing receptor activators as antidiarrheals in animals and humans1
CaSR agonists | Antidiarrheal efficacy | Ref. |
Calcium | ↑intestinal resistance, ↓bacterial colonization and translocation to Salmonella infection in rats | [81-84] |
↓intestinal permeability in rats | [108] | |
↓diarrhea severity in Salmonella enterocolitis in rats | [82] | |
↓diarrhea onset, ↓severity, ↑ recovery in DSS colitis in rodents | [73,74] | |
↓gut permeability and diarrhea in immune-mediated colitis in HLA-B27 transgenic rats | [85] | |
↓induced intestinal inflammation in mice | [35,72] | |
↓stool volume and duration of diarrheas by viruses or parasites in humans (children) | [36] | |
↓stool weight and duration of diarrhea by ETEC in humans (adults) | [87] | |
↓diarrhea frequency in patients with calcitonin-secreting medullary thyroid cancer | [88] | |
Calcium and magnesium | ↓intestinal motility and diarrhea symptoms of morphine withdrawal in mice | [62] |
Polyamines | ↓intestinal motility in mice | [63,64] |
↓gastrointestinal transit and diarrhea of irritable bowel syndrome in mice | [65-67] | |
↓DSS colitis in rodents | [73] | |
Tryptophan | ↓intestinal inflammation in mice | [109] |
↓DSS colitis in rodents | [73] |
1The naturally occurring calcium-sensing receptor (CaSR) activators described are all friendly minerals or nutrients and generally safe. Except for chemically synthesized polyamines, no adverse events other than mild GI discomforts (e.g., constipation[36,88], flatulence[88] and bloating[88]) were reported. DSS: Dextran sodium sulfate; ETEC: Enterotoxigenic Escherichia coli.